Core Insights - MustGrow Biologics Corp. reported significant improvements in potato yield and economic performance through its organic biofertility product, TerraSanteTM, in large-scale field trials conducted in Washington State and Idaho [2][3]. Group 1: Product Performance - TerraSanteTM demonstrated a consistent increase in potato yield, size, and quality at a dose rate of 11 lbs/acre, leading to an estimated increase in value of approximately US$5,000 per acre against a cost of US$180 per acre for the product [3][6]. - Large-scale trials showed a yield increase of 2 tons per acre, with larger potatoes and fewer culls, contributing to the economic benefits for farmers [6]. Group 2: Comparative Yield Data - In trials, untreated potatoes yielded 34,836 lbs/acre (15.80 tons/acre), while those treated with TerraSanteTM showed significant increases: - 15 lbs/acre application resulted in 44,468 lbs/acre (20.16 tons/acre), a 27.6% increase - 20 lbs/acre application yielded 43,838 lbs/acre (19.88 tons/acre), a 25.8% increase - 50 lbs/acre application achieved 48,497 lbs/acre (22.00 tons/acre), a 39.2% increase [4]. Group 3: Soil Health and Sustainability - TerraSanteTM focuses on enhancing soil health, nutrient and water use efficiencies, and overall crop yields, which are critical for sustainable farming practices [10][11]. - The product is designed to improve beneficial microbial activity in the soil, potentially leading to better nutrient availability and reduced plant stress [11]. Group 4: Market and Regulatory Context - TerraSanteTM is registered and approved for sale in several U.S. states, including California, Florida, Arizona, Idaho, Oregon, and Washington, under organic certification programs [9]. - The USDA reported that in 2024, 927,000 potato acres were harvested, generating a value of US$4.6 billion, highlighting the significant market potential for products like TerraSanteTM [10].